CAR-T-话题@MedSci

#CAR-T#

9篇内容 | 4652人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2241858, encodeId=3ed2224185857, content=<a href='/topic/show?id=ae97180090b' target=_blank style='color:#2F92EE;'>#T细胞#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=CAR-T治疗T细胞血液肿瘤的挑战和解决策略, objectType=article, longId=854838, objectId=c8d885483840, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202301026/1698317077220_2570354.jpg, objectUrl=/article/show_article.do?id=c8d885483840, replyNumber=0, likeNumber=7, createdTime=昨天, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c8d885483840, moduleTitle=CAR-T治疗T细胞血液肿瘤的挑战和解决策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8d885483840)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2238199, encodeId=1a6b223819998, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=6ec61050e7b0' target=_blank style='color:#2F92EE;'>#RRMM#</a>, objectTitle=【JITC】王亮教授牵头的元分析，对比CAR-T和双抗RRMM的≥3线治疗, objectType=article, longId=851728, objectId=9a77851e289f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241106/1730886962564_8538692.png, objectUrl=/article/show_article.do?id=9a77851e289f, replyNumber=0, likeNumber=22, createdTime=2024-11-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9a77851e289f, moduleTitle=【JITC】王亮教授牵头的元分析，对比CAR-T和双抗RRMM的≥3线治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9a77851e289f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2235905, encodeId=d209223590534, content=<a href='/topic/show?id=66c489335e5' target=_blank style='color:#2F92EE;'>#血液肿瘤#</a> <a href='/topic/show?id=3dcae7970d0' target=_blank style='color:#2F92EE;'>#细胞疗法#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=【JAMA】重磅综述：CAR-T和T细胞疗法治疗肿瘤的当前证据, objectType=article, longId=850226, objectId=17e98502263e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241104/1730703167443_8538692.png, objectUrl=/article/show_article.do?id=17e98502263e, replyNumber=0, likeNumber=37, createdTime=2024-11-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17e98502263e, moduleTitle=【JAMA】重磅综述：CAR-T和T细胞疗法治疗肿瘤的当前证据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17e98502263e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234031, encodeId=c80e223403139, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=【BCJ】CAR-T治疗MM的罕见并发症：免疫效应细胞相关小肠结肠炎, objectType=article, longId=849036, objectId=baf98490369b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719485454830_5579292.jpg, objectUrl=/article/show_article.do?id=baf98490369b, replyNumber=0, likeNumber=35, createdTime=2024-10-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=baf98490369b, moduleTitle=【BCJ】CAR-T治疗MM的罕见并发症：免疫效应细胞相关小肠结肠炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=baf98490369b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232836, encodeId=f1d8223283650, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=8df911095483' target=_blank style='color:#2F92EE;'>#T细胞急性淋巴细胞白血病#</a>, objectTitle=为“治无可治”的患者带来高缓解率！《自然-医学》：CAR-T治疗T系血癌再迎突破, objectType=article, longId=848236, objectId=c2d68482361b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, objectUrl=/article/show_article.do?id=c2d68482361b, replyNumber=0, likeNumber=28, createdTime=2024-10-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=c2d68482361b, moduleTitle=为“治无可治”的患者带来高缓解率！《自然-医学》：CAR-T治疗T系血癌再迎突破, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2d68482361b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232711, encodeId=470e2232e1193, content=<a href='/topic/show?id=66c489335e5' target=_blank style='color:#2F92EE;'>#血液肿瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=7d2d1802820' target=_blank style='color:#2F92EE;'>#T细胞淋巴瘤#</a>, objectTitle=未经CAR-T治疗的血液肿瘤中第二T细胞淋巴瘤的发生率，高于CAR-T的报道, objectType=article, longId=848035, objectId=61de84803536, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220804/1659603269411_8252897.webp, objectUrl=/article/show_article.do?id=61de84803536, replyNumber=0, likeNumber=58, createdTime=2024-10-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=61de84803536, moduleTitle=未经CAR-T治疗的血液肿瘤中第二T细胞淋巴瘤的发生率，高于CAR-T的报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61de84803536)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232294, encodeId=a93c2232294b8, content=<a href='/topic/show?id=18f43131be' target=_blank style='color:#2F92EE;'>#B-ALL#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=【Blood】CAR-T治疗成人B细胞ALL的现状和未来, objectType=article, longId=847887, objectId=a90984e88727, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722236145675_8538692.jpg, objectUrl=/article/show_article.do?id=a90984e88727, replyNumber=0, likeNumber=31, createdTime=2024-10-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a90984e88727, moduleTitle=【Blood】CAR-T治疗成人B细胞ALL的现状和未来, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a90984e88727)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2232083, encodeId=442122320838d, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=11bee785311' target=_blank style='color:#2F92EE;'>#细胞因子释放综合征#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a>, objectTitle=Nat Med：骨髓支持细胞因子使得AML患者对靶向CD123的CAR-T细胞产生抵抗性, objectType=article, longId=847825, objectId=e2a384e825c5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/202401020/1729423167966_2185383.png, objectUrl=/article/show_article.do?id=e2a384e825c5, replyNumber=0, likeNumber=17, createdTime=2024-10-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231787, encodeId=fef82231e87e4, content=<a href='/topic/show?id=6c1786352c6' target=_blank style='color:#2F92EE;'>#自身免疫疾病#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=Cell：首次成功！供体细胞疗法缓解自身免疫疾病，助推CAR-T疗法规模化应用新希望, objectType=article, longId=847681, objectId=6c3984e681f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240519/1716123552088_5579292.jpg, objectUrl=/article/show_article.do?id=6c3984e681f3, replyNumber=0, likeNumber=37, createdTime=2024-10-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6c3984e681f3, moduleTitle=Cell：首次成功！供体细胞疗法缓解自身免疫疾病，助推CAR-T疗法规模化应用新希望, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6c3984e681f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2230781, encodeId=c7632230e81d2, content=<a href='/topic/show?id=eaea524e90e' target=_blank style='color:#2F92EE;'>#急性髓性白血病#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性, objectType=article, longId=846916, objectId=ecb484691612, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220906/1662451499353_5552845.jpg, objectUrl=/article/show_article.do?id=ecb484691612, replyNumber=0, likeNumber=42, createdTime=2024-10-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ecb484691612, moduleTitle=赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ecb484691612)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229759, encodeId=3bc12229e59d2, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=44ca428e60' target=_blank style='color:#2F92EE;'>#CD20#</a> <a href='/topic/show?id=04481199320c' target=_blank style='color:#2F92EE;'>#难治性或复发性大B细胞淋巴瘤#</a>, objectTitle=【AJH】邹德慧/梁爱斌教授牵头，CD20 CAR-T治疗CD19 CAR-T失败的R/R LBCL的I期研究, objectType=article, longId=846066, objectId=904c84606687, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240920/1726814091434_8538692.jpg, objectUrl=/article/show_article.do?id=904c84606687, replyNumber=0, likeNumber=97, createdTime=2024-10-08, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=904c84606687, moduleTitle=【AJH】邹德慧/梁爱斌教授牵头，CD20 CAR-T治疗CD19 CAR-T失败的R/R LBCL的I期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=904c84606687)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228984, encodeId=31de222898484, content=<a href='/topic/show?id=e0d7546812c' target=_blank style='color:#2F92EE;'>#托珠单抗#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=3d742631100' target=_blank style='color:#2F92EE;'>#低纤维蛋白原血症#</a>, objectTitle=CAR-T后的CRS，托珠单抗治疗可导致低纤维蛋白原血症, objectType=article, longId=845593, objectId=0705845593e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720150214732_5579292.png, objectUrl=/article/show_article.do?id=0705845593e6, replyNumber=0, likeNumber=66, createdTime=2024-10-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=0705845593e6, moduleTitle=CAR-T后的CRS，托珠单抗治疗可导致低纤维蛋白原血症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0705845593e6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228092, encodeId=8023222809212, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=CAR-T治疗转移性结直肠癌突破！JAMA子刊：73%患者获益，总生存期超26个月, objectType=article, longId=845045, objectId=b8a584504543, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240812/1723427795598_8538692.png, objectUrl=/article/show_article.do?id=b8a584504543, replyNumber=0, likeNumber=0, createdTime=2024-09-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b8a584504543, moduleTitle=CAR-T治疗转移性结直肠癌突破！JAMA子刊：73%患者获益，总生存期超26个月, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8a584504543)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228086, encodeId=1e5222280862a, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=6ec61050e7b0' target=_blank style='color:#2F92EE;'>#RRMM#</a> <a href='/topic/show?id=33ec1196220f' target=_blank style='color:#2F92EE;'>#三类暴露#</a>, objectTitle=【Blood】CAR-T对比标准方案治疗三类暴露RRMM持续获益, objectType=article, longId=844987, objectId=0e1b84498ef1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720155679850_5579292.png, objectUrl=/article/show_article.do?id=0e1b84498ef1, replyNumber=0, likeNumber=85, createdTime=2024-09-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0e1b84498ef1, moduleTitle=【Blood】CAR-T对比标准方案治疗三类暴露RRMM持续获益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e1b84498ef1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227775, encodeId=4114222e7750f, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=3146892e7c7' target=_blank style='color:#2F92EE;'>#血液恶性肿瘤#</a>, objectTitle=【BJH】CAR-T治疗血液恶性肿瘤：从基础/转化研究到临床实践, objectType=article, longId=844697, objectId=284784469e98, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240715/1721008083562_92910.jpg, objectUrl=/article/show_article.do?id=284784469e98, replyNumber=0, likeNumber=62, createdTime=2024-09-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=284784469e98, moduleTitle=【BJH】CAR-T治疗血液恶性肿瘤：从基础/转化研究到临床实践, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=284784469e98)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2226541, encodeId=74cf222654191, content=<a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=8f6c254e71b' target=_blank style='color:#2F92EE;'>#代谢肿瘤体积#</a> <a href='/topic/show?id=997e6238ece' target=_blank style='color:#2F92EE;'>#桥接治疗#</a>, objectTitle=【CCR】桥接治疗后的代谢肿瘤体积反应可决定LBCL的CAR-T治疗结局, objectType=article, longId=843759, objectId=8e1a843e5927, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720951245077_5579292.jpg, objectUrl=/article/show_article.do?id=8e1a843e5927, replyNumber=0, likeNumber=65, createdTime=2024-09-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8e1a843e5927, moduleTitle=【CCR】桥接治疗后的代谢肿瘤体积反应可决定LBCL的CAR-T治疗结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e1a843e5927)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2226542, encodeId=5d0c22265422a, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=a80f10e3046' target=_blank style='color:#2F92EE;'>#LBCL#</a> <a href='/topic/show?id=7506114039dc' target=_blank style='color:#2F92EE;'>#18F-FDG PET/CT#</a>, objectTitle=赵维莅/王黎教授团队证实18F-FDG PET/CT在CAR-T治疗LBCL中的预后价值, objectType=article, longId=843768, objectId=07a4843e68f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722564816714_8538692.png, objectUrl=/article/show_article.do?id=07a4843e68f3, replyNumber=0, likeNumber=61, createdTime=2024-09-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=07a4843e68f3, moduleTitle=赵维莅/王黎教授团队证实18F-FDG PET/CT在CAR-T治疗LBCL中的预后价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=07a4843e68f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225872, encodeId=b87922258e228, content=<a href='/topic/show?id=970e659640a' target=_blank style='color:#2F92EE;'>#淋巴瘤#</a> <a href='/topic/show?id=793a101990ac' target=_blank style='color:#2F92EE;'>#骨髓瘤#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=【CCR】5517例淋巴瘤和骨髓瘤CAR-T治疗后的第二肿瘤：系统回顾和meta分析, objectType=article, longId=843096, objectId=a2d384309694, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721876888294_92910.jpg, objectUrl=/article/show_article.do?id=a2d384309694, replyNumber=0, likeNumber=79, createdTime=2024-09-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a2d384309694, moduleTitle=【CCR】5517例淋巴瘤和骨髓瘤CAR-T治疗后的第二肿瘤：系统回顾和meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a2d384309694)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225030, encodeId=44da2225030d3, content=<a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a> <a href='/topic/show?id=889d11892598' target=_blank style='color:#2F92EE;'>#急性脊髓病#</a>, objectTitle=【Blood】罕见但严重！CAR-T相关急性脊髓病的临床特征、病理生理及诊疗, objectType=article, longId=842608, objectId=b6fe84260827, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240725/1721893810359_8538692.png, objectUrl=/article/show_article.do?id=b6fe84260827, replyNumber=0, likeNumber=67, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b6fe84260827, moduleTitle=【Blood】罕见但严重！CAR-T相关急性脊髓病的临床特征、病理生理及诊疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6fe84260827)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221465, encodeId=11c3222146530, content=<a href='/topic/show?id=e6488633e2c' target=_blank style='color:#2F92EE;'>#自身免疫性疾病#</a> <a href='/topic/show?id=141d40627a' target=_blank style='color:#2F92EE;'>#CAR-T#</a>, objectTitle=停药后有望长期缓解！《自然》子刊：这些自身免疫性疾病患者，更适合CAR-T疗法, objectType=article, longId=839743, objectId=d8d7839e4365, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240714/1720949097955_5579292.jpg, objectUrl=/article/show_article.do?id=d8d7839e4365, replyNumber=0, likeNumber=87, createdTime=2024-08-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d8d7839e4365, moduleTitle=停药后有望长期缓解！《自然》子刊：这些自身免疫性疾病患者，更适合CAR-T疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8d7839e4365)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

CAR-T

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#T细胞# #CAR-T#

CAR-T治疗T细胞血液肿瘤的挑战和解决策略

昨天发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T# #RRMM#

【JITC】王亮教授牵头的元分析，对比CAR-T和双抗RRMM的≥3线治疗

2024-11-21发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#血液肿瘤# #细胞疗法# #CAR-T#

【JAMA】重磅综述：CAR-T和T细胞疗法治疗肿瘤的当前证据

2024-11-08发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #CAR-T#

【BCJ】CAR-T治疗MM的罕见并发症：免疫效应细胞相关小肠结肠炎

2024-10-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T# #T细胞急性淋巴细胞白血病#

为“治无可治”的患者带来高缓解率！《自然-医学》：CAR-T治疗T系血癌再迎突破

2024-10-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#血液肿瘤# #CAR-T# #T细胞淋巴瘤#

未经CAR-T治疗的血液肿瘤中第二T细胞淋巴瘤的发生率，高于CAR-T的报道

2024-10-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#B-ALL# #CAR-T#

【Blood】CAR-T治疗成人B细胞ALL的现状和未来

2024-10-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T# #细胞因子释放综合征# #AML#

2024-10-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#自身免疫疾病# #CAR-T#

Cell：首次成功！供体细胞疗法缓解自身免疫疾病，助推CAR-T疗法规模化应用新希望

2024-10-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#急性髓性白血病# #AML# #CAR-T#

赵明峰教授团队探索CLL1 CAR-T治疗髓外病变AML的疗效和安全性

2024-10-14发表于上海

梅斯管理员 (审核中...)